393 related articles for article (PubMed ID: 8246165)
1. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
Dykstra LA; Massie CA
J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
Bertalmio AJ; Woods JH
J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
[TBL] [Abstract][Full Text] [Related]
4. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
[TBL] [Abstract][Full Text] [Related]
6. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.
Brandt MR; Furness MS; Rice KC; Fischer BD; Negus SS
J Pharmacol Exp Ther; 2001 Nov; 299(2):629-37. PubMed ID: 11602675
[TBL] [Abstract][Full Text] [Related]
7. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
9. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
[TBL] [Abstract][Full Text] [Related]
10. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
Picker MJ; Cook CD
Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
Negus SS; Butelman ER; Chang KJ; DeCosta B; Winger G; Woods JH
J Pharmacol Exp Ther; 1994 Sep; 270(3):1025-34. PubMed ID: 7932149
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
14. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
Bertalmio AJ; Woods JH
J Pharmacol Exp Ther; 1989 Nov; 251(2):455-60. PubMed ID: 2553919
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
18. Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
Butelman ER; Harris TJ; Perez A; Kreek MJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):678-86. PubMed ID: 10411578
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
Dykstra LA; Gmerek DE; Winger G; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
[TBL] [Abstract][Full Text] [Related]
20. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]